ADCY5-Mosaic Variants: A Diagnosis Not to Be Missed
- PMID: 40504113
- DOI: 10.1002/mdc3.70175
ADCY5-Mosaic Variants: A Diagnosis Not to Be Missed
Abstract
Background: An increasing number of ADCY5-mosaic patients, seemingly with a milder phenotype, are being identified. However, an in-depth assessment of their clinical characteristics is lacking.
Cases: We collected and analyzed data from 12 consecutive ADCY5-mosaic patients diagnosed at our center and 7 cases from the literature; 63% of the patients presented with a baseline hyperkinetic motor disorder with paroxysmal motor exacerbations; 30% had isolated paroxysmal dyskinesias (PxD). Caffeine treatment was highly effective. Developmental delay was observed in 5 patients and especially in those with persistent motor symptoms. PxD were the initial motor symptom in 70% of cases.
Conclusions: ADCY5-mosaic carriers may have the same phenotypic spectrum as non-mosaic carriers but with a milder clinical presentation. Isolated PxD with onset in infancy are a red flag for ADCY5-mosaic variants. Particular attention should be paid when genetic analysis of patients with this phenotype is conducted as mosaicism can be easily missed.
Keywords: ADCY5‐mosaic; mixed movement disorder ADCY5 (MxMD‐ADCY5); paroxysmal dyskinesias (PxD).
© 2025 The Author(s). Movement Disorders Clinical Practice published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
References
-
- Friedman JR, Méneret A, Chen D‐H, Trouillard O, Vidailhet M, Raskind WH, Roze E. ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias. Mov Disord 2016;31:147–148.
-
- Delorme C, Giron C, Bendetowicz D, Méneret A, Mariani L‐L, Roze E. Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders. Expert Rev Neurother 2021;21:81–97.
-
- Menon PJ, Nilles C, Silveira‐Moriyama L, et al. Scoping review on ADCY5‐related movement disorders. Mov Disord Clin Pract 2023;10:1048–1059.
-
- Chen D‐H, Méneret A, Friedman JR, et al. ADCY5‐related dyskinesia: broader spectrum and genotype‐phenotype correlations. Neurology 2015;85:2026–2035.
-
- Méneret A, Mohammad SS, Cif L, et al. Efficacy of caffeine in ADCY5‐related dyskinesia: a retrospective study. Mov Disord 2022;37:1294–1298.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources